Inhibition of DDX3 modulates immune signaling in aggressive breast cancers. Vesuna F, Winnard PT Jr, van Voss MH, Bol GM, et al. Cancer Lett 2025;634:218065.

Read + Share

Amedeo Smart

Independent Medical Education

Vesuna F, Winnard PT Jr, van Voss MH, Bol GM, et al. Inhibition of DDX3 modulates immune signaling in aggressive breast cancers. Cancer Lett 2025;634:218065.
PMID: 41016677